You are here: Home » Companies » News
Business Standard

CBI probing Surya Pharmaceuticals in Rs 6.2 billion bank fraud case

The finance ministry had earlier asked all banks to step up vigilance following a $2 billion fraud in February at India's second-biggest state-run lender Punjab National Bank

Reuters  |  New Delhi 

Indian police have launched an investigation into a Delhi-based pharmaceutical company for allegedly defrauding state-run Punjab & Sind Bank and four other banks of 6.21 billion rupees ($94.57 million), police said. "Investigation is continuing," Central Bureau of Investigation (CBI), the federal police, said in a statement on Tuesday. The CBI said the searches were conducted at seven locations and recovered some documents. The police acted following a complaint from the Punjab & Sind Bank against Surya Pharmaceuticals , its two promoters and a Dubai-based company, ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Wed, April 18 2018. 01:58 IST